Tuberculosis, Multidrug-Resistant

Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB

Training Protocol on the Natural History of Tuberculosis

Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents With Pulmonary MDR-TB

Bioneer Q-RFIA Clinical Evaluation

Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis

Linezolid Dosing Strategies in Drug-Resistant TB

Study of TB Lesions Obtained in Therapeutical Surgery

Evaluating Newly Approved Drugs for Multidrug-resistant TB

Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)

An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)

A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis

Treatment Shortening of MDR-TB Using Existing and New Drugs

Strengthening Evidence on Optimal Multidrug-resistant Tuberculosis Treatment Regimens

Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)

Hotspots, Households and Hospitals: Enhanced Drug-resistant Tuberculosis Case Finding in Namibia

Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s)

Nosocomial Transmission of MDR-TB in Bucharest, Romania

Biomarkers for Therapy Response in Drug-resistant Tuberculosis

Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients

PredictEndTB Signature for Individualizing Treatment in Multidrug-Resistant Tuberculosis